Baseline characteristics and response to GH replacement of hypopituitary patients previously irradiated for pituitary adenoma or craniopharyngioma: data from the Pfizer International Metabolic Database | Zendy

Dominique Maiter | Zendy; Roger Abs | Zendy; Gudmundur Johannsson | Zendy; MF Scanlon | Zendy; Pernilla Jönsson | Zendy; Patrick Wilton | Zendy; Maria KołtowskaHäggström | Zendy

Open Access

Baseline characteristics and response to GH replacement of hypopituitary patients previously irradiated for pituitary adenoma or craniopharyngioma: data from the Pfizer International Metabolic Database

Author(s) -

Dominique Maiter,

Roger Abs,

Gudmundur Johannsson,

MF Scanlon,

Pernilla Jönsson,

Patrick Wilton,

Maria KołtowskaHäggström

Publication year - 2006

Publication title -

european journal of endocrinology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.897

H-Index - 148

eISSN - 1479-683X

pISSN - 0804-4643

DOI - 10.1530/eje.1.02209

Subject(s) - craniopharyngioma , medicine , endocrinology , pituitary adenoma , growth hormone deficiency , radiation therapy , hypopituitarism , pituitary neoplasm , adenoma , pituitary gland , database , growth hormone , hormone , computer science

To test the hypothesis whether the effects of GH replacement therapy in adults could be affected by prior pituitary irradiation, the baseline characteristics and response to GH were evaluated in adults with severe GH deficiency (GHD), who had received or not irradiation for the treatment of pituitary adenoma or craniopharyngioma.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research